[Disk diffusion method for fluconazole susceptibility testing of Candida spp. isolates].
In order to standardize and evaluate a disk diffusion method with visual reading to detect in vitro fluconazole susceptibility of yeast, 1193 clinical isolates were tested. These included 584 Candida albicans, 196 Candida parapsilosis, 200 Candida tropicalis, 113 Candida glabrata, 50 Candida krusei and 50 Candida spp. and other opportunistic yeasts. The disks were manufactured in the INEI-ANLIS "Dr. Carlos G. Malbrán. The disk diffusion method results were compared to MIC results obtained by the reference CLSI M27-A2 broth microdilution method modified by EUCAST. The interpretative breakpoints for in vitro susceptibility testing of fluconazole were established at: zone diameter > or =16 mm for MIC < or =8 microg/ml (susceptible isolates), between 9 and 15 mm for MIC = 16-32 microg/ml (susceptible dose-dependent isolates), and < or =8 mm for MIC > or =64 microg/ml (resistant isolates). Overall agreement between the two methods was 94.7%, with 0.2% very major errors, and 0.3% major errors. Inter - and intralaboratory agreement was good. The disk diffusion method for drug susceptibility testing of Candida spp. isolates is inexpensive, reliable and reproducible. However, when the inhibition zone diameter is < or =15 mm, it is advisable to test the isolate by the reference microdilution method.
Rodero
L
L
Departamento Micología, INEI ANLIS Dr. Carlos G. Malbran, Avenida Vélez Sarsfield 563 (C1282AFF) Ciudad Autónoma de Buenos Aires, Argentina.
Córdoba
S
S
Vivot
W
W
Campo
M
M
Corfield
P
P
Olguín
C
C
Cuirolo
A
A
Soria
M
M
Guelfand
L
L
Canteros
C E
CE
Davel
G
G
D000935:Antifungal Agents / Q000494:pharmacology*; D002175:Candida / Q000187:drug effects* / Q000302:isolation & purification; D003430:Cross-Sectional Studies; D052978:Disk Diffusion Antimicrobial Tests; D015725:Fluconazole / Q000494:pharmacology*; D006801:Humans; D011446:Prospective Studies
D000935:Antifungal Agents; D015725:Fluconazole